These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19712076)

  • 21. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?
    Daugherty SL; Peterson PN; Wang Y; Curtis JP; Heidenreich PA; Lindenfeld J; Vidaillet HJ; Masoudi FA;
    Am Heart J; 2009 Aug; 158(2):224-9. PubMed ID: 19619698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest.
    Birnie DH; Sambell C; Johansen H; Williams K; Lemery R; Green MS; Gollob MH; Lee DS; Tang AS
    CMAJ; 2007 Jul; 177(1):41-6. PubMed ID: 17606938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends and predictors of implantable cardioverter defibrillator implantation after sudden cardiac arrest: Insight from the national inpatient sample.
    Munir MB; Alqahtani F; Aljohani S; Bhirud A; Modi S; Alkhouli M
    Pacing Clin Electrophysiol; 2018 Mar; 41(3):229-237. PubMed ID: 29318626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States.
    Tsai V; Goldstein MK; Hsia HH; Wang Y; Curtis J; Heidenreich PA;
    Circ Cardiovasc Qual Outcomes; 2011 Sep; 4(5):549-56. PubMed ID: 21878667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
    Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
    Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
    Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of short- and long-term outcomes by electrocardiography in survivors of out-of-hospital cardiac arrest.
    Bunch TJ; White RD; Bruce GK; Hammill SC; Gersh BJ; Shen WK; Carter MA; Packer DL
    Resuscitation; 2004 Nov; 63(2):137-43. PubMed ID: 15531064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital readmission in patients with implantable cardioverter-defibrillators.
    Kaźmierczak J; Zielonka J; Rzeuski R; Peregud-Pogorzelska M; Goracy J; Biernawska J; Sulikowski T; Kornacewicz-Jach Z
    Kardiol Pol; 2006 Jul; 64(7):684-91; discussion 692-3. PubMed ID: 16886125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian variations of ventricular tachyarrhythmias detected by the implantable cardioverter-defibrillator.
    Auricchio A; Klein H
    G Ital Cardiol; 1997 Feb; 27(2):113-22. PubMed ID: 9199946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Olshansky B; Wood F; Hellkamp AS; Poole JE; Anderson J; Johnson GW; Boineau R; Domanski MJ; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2007 Jun; 153(6):1089-94. PubMed ID: 17540216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing the decision to ICD implantation in survivors of OHCA and its influence on long term survival.
    Martinell L; Herlitz J; Lindqvist J; Gottfridsson C
    Resuscitation; 2013 Feb; 84(2):213-7. PubMed ID: 22922177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest.
    Chan PS; Krumholz HM; Spertus JA; Curtis LH; Li Y; Hammill BG; Nallamothu BK;
    Am Heart J; 2015 Jun; 169(6):870-878.e1. PubMed ID: 26027626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest.
    Groeneveld PW; Heidenreich PA; Garber AM
    Circulation; 2003 Jul; 108(3):286-91. PubMed ID: 12835222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trend in implantable cardioverter defibrillators and relation to need.
    Giammaria M; Bruna C; Gnavi R;
    J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):265-70. PubMed ID: 20010110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inequitable distribution of implantable cardioverter defibrillators in Ontario.
    Udell JA; Juurlink DN; Kopp A; Lee DS; Tu JV; Mamdani MM
    Int J Technol Assess Health Care; 2007; 23(3):354-61. PubMed ID: 17579939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights.
    Voigt A; Shalaby A; Saba S
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):414-9. PubMed ID: 19793359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.